L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes

NCT00329498 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Myelodysplastic Syndrome

Interventions

DRUG: L-Ascorbic Acid

Sponsor

Samsung Medical Center

Collaborators

[object Object]